Lv12
40 积分 2023-06-12 加入
多学科模式下洛拉替尼不良反应处理专家共识
5小时前
待确认
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
9个月前
已完结
MetastaticHER2-amplified non-small-cell lung cancer treated with trastuzumab deruxtecan
1年前
已完结
Tracking Clonal Evolution of EGFR-Mutated Non-Small Cell Lung Cancer Through Liquid Biopsy: Management of C797S Acquired Mutation
1年前
已完结
[Chinese expert consensus on the diagnosis and treatment of chemotherapy-induced peripheral neuropathy (2022 edition)]
1年前
已完结
[Chinese expert consensus on lipid management in patients with malignancy]
1年前
已完结
中国肿瘤患者围术期疼痛管理专家共识（2020版）
1年前
已完结
[Efficacy and safety of non-vitamin K antagonist versus vitamin K antagonist oral anticoagulants in the prevention and treatment of thrombotic disease in active cancer patients: a systematic review and meta-analysis of randomized controlled trials]
1年前
已完结
Perioperative treatment strategies in EGFR-mutant early-stage NSCLC: current evidence and future challenges
1年前
已完结
Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study
1年前
已完结
皖公网安备34019202002308
